home

clinical

refractive

Clinical

Videos

Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.

Examining 10-year postop data on epi-off CXL for keratoconus, ectasia 

Articles

According to Oculus, its Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via an inbuilt display.

FDA grants clearance for myopia device

Silverstein is a founding partner of Silverstein Eye Centers, in Kansas City, Missouri. He is also an assistant professor of ophthalmology at the University of Missouri Kansas City Medical School, and clinical professor of ophthalmology at Kansas City University of Medicine and Biosciences. 

E: ssilverstein@silversteineyecenters.com

Taking control of a practice’s future with investment, creative thinking

Four tips for growing a proactive practice

Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia. 

Outcomes of LASIK utilising new topography-integrated aberrometer 

Kathryn M. Hatch, MD, details how collagen CXL is evolving with the goals of reducing complications and actually improving visual acuity.

Exploring collagen cross-linking as a treatment for keratoconus

Dr. Devgan, assistant clinical professor, Jules Stein Eye Institute, University of California, Los Angeles.

Podcasts

Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.

What patients need to know about cataract surgery

Investigators find little difference between the options.

IOL dilemma: Replacement or rescue 

Refractive Surgery

Refractive

Investigators examine usefulness in refractive surgery evaluations.

Study targets utility of epithelial thickness mapping 

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Early experience with next-generation lens engenders positive perception.

Presbyopia-correcting IOL improves vision for patients

George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial of AGN-190584 (pilocarpine, pilocarpine, 1.25% eye drops) for the treatment of presbyopia.